Carolyn M Tastad is CEO - Health Care of PROCTER & GAMBLE Co. Currently has a direct ownership of 28,156 shares of PG, which is worth approximately $4.71 Million. The most recent transaction as insider was on Mar 01, 2022, when has been sold 3,730 shares (Common Stock) at a price of $153.51 per share, resulting in proceeds of $572,592. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.2K
0% 3M change
0% 12M change
Total Value Held $4.71 Million

CAROLYN M TASTAD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
SELL
Open market or private sale
$572,592 $153.51 p/Share
3,730 Reduced 11.7%
28,156 Common Stock
Dec 06 2021
SELL
Payment of exercise price or tax liability
$40,779 $148.83 p/Share
274 Reduced 0.86%
31,717 Common Stock
Dec 06 2021
BUY
Exercise of conversion of derivative security
$9,227 $148.83 p/Share
62 Added 0.19%
31,992 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
3,251 Added 9.29%
31,748 Common Stock
Aug 19 2021
SELL
Open market or private sale
$2,224,118 $143.9 p/Share
15,456 Reduced 35.16%
28,497 Common Stock
Aug 17 2021
SELL
Open market or private sale
$1,832,921 $144.37 p/Share
12,696 Reduced 22.41%
43,953 Common Stock
Aug 17 2021
BUY
Grant, award, or other acquisition
-
28,152 Added 33.2%
56,649 Common Stock
Aug 02 2021
SELL
Open market or private sale
$1,101,836 $141.77 p/Share
7,772 Reduced 21.53%
28,332 Common Stock
May 26 2021
SELL
Open market or private sale
$414,600 $138.2 p/Share
3,000 Reduced 7.67%
36,104 Common Stock
May 11 2021
SELL
Open market or private sale
$482,230 $137.27 p/Share
3,513 Reduced 8.28%
38,935 Common Stock
Feb 26 2021
SELL
Open market or private sale
$991,068 $125.77 p/Share
7,880 Reduced 15.66%
42,448 Common Stock
Dec 15 2020
SELL
Payment of exercise price or tax liability
$50,224 $136.85 p/Share
367 Reduced 0.73%
50,133 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$9,169 $136.85 p/Share
67 Added 0.13%
50,501 Common Stock
Nov 12 2020
SELL
Bona fide gift
-
700 Reduced 1.37%
50,259 Common Stock
Oct 27 2020
SELL
Open market or private sale
$7,413,869 $142.94 p/Share
51,867 Reduced 50.44%
50,959 Common Stock
Oct 27 2020
BUY
Exercise of conversion of derivative security
$3,976,124 $76.66 p/Share
51,867 Added 38.94%
81,330 Common Stock
Oct 01 2020
BUY
Grant, award, or other acquisition
-
2,969 Added 5.51%
50,959 Common Stock
Aug 19 2020
SELL
Open market or private sale
$2,589,848 $136.0 p/Share
19,043 Reduced 28.41%
47,990 Common Stock
Aug 18 2020
SELL
Open market or private sale
$2,297,936 $136.53 p/Share
16,831 Reduced 20.07%
67,033 Common Stock
Aug 18 2020
BUY
Grant, award, or other acquisition
-
35,874 Added 29.96%
83,864 Common Stock
Jul 31 2020
SELL
Open market or private sale
$1,224,080 $130.0 p/Share
9,416 Reduced 16.45%
47,824 Common Stock
Feb 28 2020
SELL
Open market or private sale
$181,232 $110.44 p/Share
1,641 Reduced 2.98%
53,421 Common Stock
Feb 28 2020
BUY
Grant, award, or other acquisition
-
3,622 Added 5.97%
57,043 Common Stock
Feb 27 2020
SELL
Open market or private sale
$622,345 $117.49 p/Share
5,297 Reduced 8.78%
55,062 Common Stock
Jan 28 2020
SELL
Open market or private sale
$4,720,978 $126.28 p/Share
37,385 Reduced 38.31%
60,190 Common Stock

Also insider at

K
KELLOGG CO Consumer Defensive
CMT

Carolyn M Tastad

CEO - Health Care
Cincinnati, OH

Track Institutional and Insider Activities on PG

Follow PROCTER & GAMBLE Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PG shares.

Notify only if

Insider Trading

Get notified when an Procter & Gamble CO insider buys or sells PG shares.

Notify only if

News

Receive news related to PROCTER & GAMBLE Co

Track Activities on PG